Cerus Corporation
CERS
#7220
Rank
S$0.74 B
Marketcap
S$3.73
Share price
-3.68%
Change (1 day)
107.98%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -S$9.6 Million

According to Cerus Corporation's latest financial reports the company's current earnings are S$0.19 Billion. In 2024 the company made an earning of -S$15.38 Million, an increase over its 2023 earnings that were of -S$37.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$9.6 Million-37.61%
2024 -S$15.38 Million-58.95%
2023 -S$37.45 Million-20.74%
2022 -S$47.24 Million-25.7%
2021 -S$63.58 Million-11.99%
2020 -S$72.24 Million-14%
2019 -S$84 Million21.73%
2018 -S$69.01 Million-0.65%
2017 -S$69.46 Million-10.96%
2016 -S$78.01 Million4.24%
2015 -S$74.84 Million50.99%
2014 -S$49.57 Million-10.08%
2013 -S$55.12 Million184.13%
2012 -S$19.4 Million-7.91%
2011 -S$21.07 Million
2009 -S$29.75 Million-24.69%
2008 -S$39.51 Million-25.2%
2007 -S$52.82 Million330.54%
2006 -S$12.27 Million1.49%
2005 -S$12.09 Million-61.02%
2004 -S$31.01 Million
2002 -S$76.7 Million10.02%
2001 -S$69.72 Million34.25%
2000 -S$51.93 Million61.02%
1999 -S$32.26 Million-18.81%
1998 -S$39.73 Million93.08%
1997 -S$20.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.84 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
S$18.91 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
S$0.32 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.28 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA